Femme et Homme
- | Pays :
- Czech Republic
- United Kingdom
- Australia
- Les 12 autres...
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this study is to determine whether patients with high-risk myelodysplastic syndromes (MDS) treated with azacitidine have improved survival compared to conventional care treatments. The study will also assess the effect of treatments on response, duration of response, and transformation to acute myeloid leukemia (AML). The study will continue for 12 months following last patient enrolled. See study AZA PH GL 2003 CL 001 E for information about the extension to this study.
Critère d'inclusion
- Myelodysplastic syndromes